345 Currently, clinical trials are being performed for the ATO treatment of dysfunctional p53 (Table 3)
Of those, nine samples could not be amplified and genotyped by real-time PCR, leading to 3% of false-negative results
The HA-enriched outer layers maintain hydration, modulate immune responses, and support epithelial migration, while GSH-loaded inner cores buffer ROS accumulation and sustain redox homeostasis [33]
Injections can be given at any time of day, with or without food, as long as the same day each week is maintained
[DOI] [PMC free article] [PubMed] [Google Scholar] 29.Deganutti G., Liang Y.L., Zhang X., Khoshouei M., Clydesdale L., Belousoff M.J., Venugopal H., Truong T.T., Glukhova A., Keller A.N., et al